Valuation: 3billion, Inc.

Market Cap 19TCr 13Cr 11Cr 10Cr 9.39Cr 18Cr 1.22TCr 18Cr 121.7Cr 48Cr 595.51Cr 47Cr 46Cr 2.05TCr P/E 2025
-107x
P/E 2026 * -
Enterprise Value 17Cr 1L 1L 92.65T 85.4T 2L 1.11Cr 2L 11.07L 4L 54.19L 4L 4L 1.87Cr EV / Sales 2025
49x
EV / Sales 2026 * -
Free-Float
75.48%
Yield 2025 *
-
Yield 2026 * -
1 day+4.24%
Current month-2.48%
1 month-12.20%
3 months-53.69%
6 months-60.75%
Current year-67.64%
1 week 5,310
Extreme 5310
6,160
1 month 5,310
Extreme 5310
6,780
Current year 5,310
Extreme 5310
18,690
1 year 5,310
Extreme 5310
20,100
3 years 3,025
Extreme 3025
20,100
5 years 3,025
Extreme 3025
20,100
10 years 3,025
Extreme 3025
20,100
Manager TitleAgeSince
Chief Executive Officer 45 10/10/2016
Director of Finance/CFO 46 01/10/2020
Chief Tech/Sci/R&D Officer 46 01/08/2018
Director TitleAgeSince
Director/Board Member 45 10/10/2016
Director/Board Member 44 10/10/2016
Director/Board Member 44 18/11/2020
Date Insider Type Main position Quantity % Market Cap.
16/04/25 Others

Chief Financial Officer

44,000 0.1387%
07/03/25 Fiscal year 10,000 0.0316%
07/03/25 Others 2,20,600 0.6963%
Change 5-day change 1-year change 3-year change Capi.($)
+4.24%0.00%-18.40% - 13Cr
+0.95%-.--%+107.91%+6.38% 2TCr
-0.15%+3.79%+151.51%+101.95% 471.81Cr
+3.71%+8.83%+120.60%+195.74% 366.82Cr
+7.30%+18.20%+124.22%-35.90% 223.25Cr
-1.51%+39.35%+233.45%+286.48% 205.24Cr
-5.50%-0.75%-29.67%-37.57% 203.53Cr
+2.12%+18.88%+197.94%-42.31% 106.79Cr
-2.39%-1.55%-10.78%+34.35% 87Cr
-4.16%+6.17%-34.21%-11.42% 51Cr
Average +0.46%+9.44%+84.26%+55.30% 373.14Cr
Weighted average by Cap. +0.87%+5.13%+112.46%+46.71%

Financials

2025 2026 *
Net sales 1.08TCr 72.63L 63.47L 58.57L 53.99L 1.02Cr 70Cr 1.04Cr 7Cr 2.75Cr 34Cr 2.73Cr 2.67Cr 117.92Cr -
Net income -580Cr -39L -34.09L -31.45L -28.99L -54.65L -38Cr -55.86L -3.76Cr -1.48Cr -18Cr -1.46Cr -1.43Cr -63Cr -
Net Debt -1.69TCr -1.14Cr -99.32L -91.65L -84.48L -1.59Cr -109.45Cr -1.63Cr -11Cr -4.31Cr -54Cr -4.27Cr -4.17Cr -184.53Cr -
Logo 3billion, Inc.
3Billion Inc is a Korea-based company principally engaged in the provision of genetic testing services. The Company is principally engaged in the provision of rare genetic disease diagnostic testing services. The Company is also engaged in the research and development of technology that automatically reads the pathogenicity of numerous genetic variants found in the genome.
Employees
-
Date Price Change Volume
16/26/16 ₩5,900.00 +4.24% 2,29,768
15/26/15 ₩5,660.00 +4.24% 1,08,227
14/26/14 ₩5,430.00 -3.72% 4,24,867
13/26/13 ₩5,640.00 -4.41% 1,09,518

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A394800 Stock